BioMed Research International

BioMed Research International / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 1087647 | 10 pages | https://doi.org/10.1155/2016/1087647

Glia-Neuron Interactions in the Retina Can Be Studied in Cocultures of Müller Cells and Retinal Ganglion Cells

Academic Editor: Xu Wang
Received24 Feb 2016
Revised27 Apr 2016
Accepted19 May 2016
Published26 Jun 2016

Abstract

Glia-neuron partnership is important for inner retinal homeostasis and any disturbances may result in retinal ganglion cell (RGC) death. Müller cells support RGCs with essential functions such as removing excess glutamate and providing energy sources. The aim was to explore the impact of Müller cells on RGC survival. To investigate the Müller cell/RGC interactions we developed a coculture model, in which primary Müller cells were grown in inserts on top of pure primary RGC cultures. The impact of starvation and mitochondrial inhibition on the Müller cell ability to protect RGCs was studied. Moreover, the ability of Müller cells to remove glutamate from the extracellular space was investigated. RGC survival was evaluated by cell viability assays and glutamate uptake was assessed by kinetic uptake assays. We demonstrated a significantly increased RGC survival in presence of untreated and prestarved Müller cells. Additionally, prestarved Müller cells significantly increased RGC survival after mitochondrial inhibition. Finally, we revealed a significantly increased ability to take up glutamate in starved Müller cells. Overall, our study confirms essential roles of Müller cells in RGC survival. We suggest that targeting Müller cell function could have potential for future treatment strategies to prevent blinding neurodegenerative retinal diseases.

1. Introduction

Interactions between the most inner retinal neurons, the retinal ganglion cells (RGCs), and the most abundant retinal glial cells, the Müller cells, are essential to a functional retinal homeostasis. Müller cells span the entire thickness of the retina from the inner nerve fiber layer near the vitreous to the outer segment near the retinal pigment epithelium. The Müller cells are specialized radial glial cells and constitute an anatomical and functional link between neurons and the cellular environment such as blood vessels, the vitreous chamber, and subretinal space. They play a pivotal role in maintaining the structural integrity of the retina as well as sustaining the retinal homeostasis by participating in essential processes such as glucose metabolism, substrate exchange, and vascular regulation [1, 2].

Virtually every aspect of inner retinal homeostasis and function involves a glia-neuron partnership. Growing evidence supports this particular interaction as being fundamental for different aspects of neurodegenerative retinal diseases [24]. However, the present knowledge about the partnership between RGCs and Müller cells is limited. The pathological mechanisms of neurodegenerative diseases in the retina are still being debated and there are various hypotheses concerning the cause of the RGC death. Particularly glutamate excitotoxicity [58], mitochondrial dysfunction [912], oxidative stress [9, 13, 14], disturbed energy metabolism [1518], altered autoregulation [19, 20], and finally sparse studies on disturbed Müller cell function [3, 5, 15] are among the discussed precursors of RGC death.

The most abundant excitatory neurotransmitter in the central nervous system, including the retina, is the amino acid glutamate [21]. Glutamate is taken up by glutamate transporters into the Müller cells and hence the glutamate transporters are ultimately responsible for balancing the extracellular glutamate level between physiological signalling and pathological overactivation. In Müller cells the predominant glutamate transporter is the excitatory amino acid transporter 1 (EAAT1, also known as GLAST) [22, 23]. We have previously reported that cell cultures of the human Müller glia cell line, MIO-M1 [24], are capable of increasing their glutamate uptake and their expression of EAAT1 during starvation [15], thus indicating a regulatory mechanism to prevent excitotoxicity of the RGCs.

Previous studies have reported improved survival of RGCs cultured with retinal glia cells [5, 2528]. To the best of our knowledge there have been no studies examining the consequences of energy starvation on the Müller cell ability to promote RGC survival. Here, we describe a coculture model to study the glia-neuron interaction. We explore the effects of prestarvation and starvation on survival of primary Müller cells and primary RGCs. Furthermore, we examine the effect of starvation and mitochondrial inhibition on primary Müller cell viability and primary RGC viability. Finally, we investigate the capacity of glutamate uptake in Müller cells during starvation.

Our study provides knowledge of interactions between primary RGCs and primary Müller cells in a coculture system. We show a significant increase in RGC survival in presence of Müller cells. A significant Müller cell protection is found in both untreated cocultures as well as in prestarved cocultures and in prestarved cocultures with inhibited mitochondrial function. Finally, we demonstrate an increased capacity of Müller cells to transport glutamate during starvation. Overall, our study suggests a vital role of Müller cells in the RGC survival.

2. Materials and Methods

2.1. Primary Cell Cultures

Primary Müller cells and primary retinal ganglion cells were cultured from dissected retinas of neonatal mice (C57Bl/6J, Charles River, Germany) at postnatal day 6–8 or 5, respectively. The mice were sacrificed by cervical dislocation and the eyes were enucleated into D-PBS. Retinas were carefully dissected under a microscope (Leica S4E).

2.2. RGC Purification

Cultures of primary RGCs were purified by sequential immunopanning as described by the group of Professor Barres [29, 30]. Briefly, dissected retinas were digested with papain at 37°C for 45 minutes, which was terminated by rinsing the cells in buffers containing increasing concentrations of ovomucoid (20–40 mg/mL). Following a gentle trituration, the retinal cells were resuspended in panning buffer containing insulin (5 μg/mL), filtered through a 20 μm nylon mesh, and then incubated with rabbit anti-macrophage antibody (AIA51240, Accurate Chemical, USA). Retinal cells were incubated sequentially on three immunopanning dishes: the first two coated with anti-rabbit secondary antibodies (goat anti-rabbit IgG, 611-1102, Rockland, USA) and the third with a RGC specific Thy-1 antibody (LS-C14009, LifeSpan, USA). The Thy-1 plate was rinsed multiple times with EBSS. RGCs were released from the final panning dish with trypsin (Sigma-Aldrich, USA) and the trypsinization was terminated using Neurobasal medium (12349-015, Gibco by Life Technologies, USA) containing 33% fetal bovine serum (Biological Industries, Israel). RGCs were plated at high density (150.000 cells/cm2) on poly-D-lysine (10 μL/mL, Sigma-Aldrich) and laminin (10 μg/mL, Sigma-Aldrich) coated cell culture plates (TPP, Switzerland). The RGCs were kept in culture in a 37°C humidified atmosphere with 10% CO2 for 6 days in ND-growth medium with change of a third of the medium volume on the third day in culture. The ND-growth culture medium is formulated from Neurobasal medium mixed in equal amounts with DMEM high-glucose medium (31966, Gibco) with addition of penicillin (1000 units/mL), streptomycin (1000 μg/mL), insulin (0.5 μg/mL), sodium pyruvate (1.5 mM), 3,3′,5-Triiodo-L-thyronine (40 ng/mL), L-glutamine (3.7 mM), B27 supplement (1x, Gibco), and trace elements B (1x, Cellgro, USA). The medium was supplemented with a Sato stock consisting of transferrin (100 μg/mL), BSA (100 μg/mL), progesterone (0.63 ng/mL), putrescine (16 μg/mL), and sodium selenite (40 ng/μL). Finally, we added NAC (5 μg/mL), biotin (10 ng/mL), BDNF (50 ng/mL, 248-BD-025, R&D Systems, UK), CNTF (10 ng/mL, 257-NT-010, R&D Systems), FGFb (10 ng/mL, PMG0034, Gibco), and forskolin (4,2 μg/mL) to the medium.

2.3. Müller Cell Purification

The Müller cells were cultured essentially as described by Hicks and Courtois [31]. Briefly, the dissected retinas were incubated for 30 minutes in DMEM (21885, Gibco) supplemented with collagenase (65 U/mL) and trypsin (0.25%). Afterwards, the cells were rinsed twice in DMEM containing 10% fetal bovine serum (Gibco) to terminate the digestion. The digested retinas were mechanically dissociated by gentle trituration through a 14 G needle producing a suspension of tissue microaggregates and single cells. Cells were seeded in tissue culture plates or flasks (TPP) or on 0.4 μm membrane inserts (Falcon, USA) at a density of 0.6 retina/cm2. Cells were maintained at 37°C in a humidified atmosphere with 5% CO2 cultured in DMEM containing glucose (1.0 g/L), pyruvate (1 mM), L-alanyl-glutamine (3.97 mM), supplemented with penicillin (90 Units/mL) and streptomycin (90 μg/mL), and 10% fetal bovine serum (Gibco). The cells were kept in culture for 10–14 days with culture medium changed twice a week. Aggregates and debris were removed by forcible resuspension of medium onto the cell monolayer. Cell cultures of approximately 80–90% confluency were used for experiments.

2.4. Immunocytochemistry

Immunocytochemistry was performed on cultures of primary Müller cells cultured for 10 days on poly-D-lysine coated cover glass slides and primary retinal ganglion cells cultured on poly-D-lysine/laminin coated cover glass slides for 6 days. The cells were normal conditioned before the fixation. Briefly, the cells were fixed with 4% paraformaldehyde for 20 minutes at room temperature and the membranes were permeated using 0.02 mol/L glycine and 0.1% Triton-X-100 in PBS for 30 minutes at room temperature. Unspecific binding sites were blocked using 3% freshly diluted BSA (A8806, Sigma-Aldrich) for 1 hour at 4°C. Cell cultures were immunostained using a primary antibody against either glutamine synthetase (GS, G2781, Sigma-Aldrich, 1 : 200), excitatory amino acid transporter 1 (EAAT1, AB416, Abcam, UK, 1 : 200), microtubule associated protein 2 (MAP2, M4403, Sigma-Aldrich, 1 : 500), or growth associated protein-43 (GAP-43, AB5220, Millipore, USA, 1 : 500) combined with Alexa Fluor 488 (A11034, Invitrogen, USA) or Texas Red (T862, Invitrogen) as secondary antibody. On some slides nuclei were counterstained with 0.3 μmol/L DAPI (D3571, Invitrogen) for 3 minutes. Negative controls were treated without primary antibody. The slides were mounted with fluorescent mounting medium (Dako, Denmark) and sealed with nail polish. For RGCs, images were obtained using an iMIC confocal microscope (Till Photonics, FEI, Germany) equipped with appropriate filter settings for detecting DAPI, CY2/Alexa488, and Texas Red/Alexa561/594. The iMIC was equipped with the following objectives: ×20, numerical aperture (NA) = 0.75. The images of the cell culture were stitched together using the LA Stitch plug-in in Fiji software (version 1.47q, NIH, USA) to create an image of the entire culture. For Müller cells, fluorescence microscopy was performed using LEICA DMIL LED equipped with filter cubes (DAPI, GFP ET, and TX2 ET) and Leica Application Suite V4. Pictures were captured using Leica DFC420 C Digital Microscope Camera and analysed using Photoshop CS6.

2.5. Experimental Incubations

Our study included different types of media for different types of experiments. Müller Cells. A DMEM medium (A14430, Gibco) with a formulation of amino acids and typical extracellular concentrations of inorganic salts was used for incubations of monocultures of Müller cells. In the control incubations the DMEM was added 6 mM glucose, 1 mM pyruvate, and 2.5 mM glutamine. Prestarvation or starvation of Müller cells was performed by incubation for 24 hours in the DMEM by omitting glucose, pyruvate, and glutamine. All incubations of monocultures with Müller cells were performed at 37°C and 5% CO2. RGCs. For monocultures of RGCs and cocultures of RGCs and Müller cells, the control medium consisted of the ND-growth medium detailed in the methods section above for RGC culturing (containing 25 mM glucose, 1.5 mM pyruvate, and 3.7 mM glutamine). For the starvation experiments the Neurobasal (05-0128DJ, Gibco) and DMEM (A14430, Gibco) components of the ND-growth medium were replaced with glucose-, pyruvate-, and glutamine-free alternatives with otherwise identical compositions. All incubations involving RGCs were at 37°C and 10% CO2. To block mitochondrial activity 10 μM antimycin A was added to the incubation medium.

2.6. LDH Toxicity Assays

Lactate dehydrogenase (LDH) cell cytotoxicity kit (Takara Bio Inc., Japan) was used to quantitatively assess cell survival. The medium was changed and the cells were starved (in absence of glucose, glutamine, and pyruvate), treated with 10 μM antimycin A, or left untreated (control) for 24 hours. Plates were centrifuged at 500 RPM for 10 minutes, and the supernatants were used for LDH determination as a measure of cell viability. The LDH yield participates in a coupled reaction that converts yellow tetrazolium salts into a red formazan product, which was measured as a 490 nm absorbance reading. Each LDH analysis was performed in triplicate and corrected on single sample/well basis and correlated to total cell death by Triton-X in each sample/well.

2.7. MTT Viability Assay

As a second viability assay, Müller cell survival was determined by the colorimetric method, MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide), measuring the ability of viable cells to reduce MTT to a purple formazan salt, which can be measured at absorbance 560 nm. The Müller cell cultures were incubated in either starvation DMEM or starvation DMEM treated with 1 mM glutamate or left untreated (control DMEM) for 24 hours. Subsequently, the cells were incubated with 12 mM MTT solution for one hour at 37°C and the cells were solubilized in 10% SDS and 0.01 M HCl. Eighteen hours later, the absorbance at 560 nm was measured. The background readings (blank wells with medium, MTT solution, and solubilization buffer) were subtracted from the absorbance readings of the treated wells to obtain an adjusted absorbance reading representing cell viability. Finally, the readings were divided by the adjusted absorbance readings of untreated (control) cells to obtain a percentage of cell survival.

2.8. Glutamate Uptake Assay

The kinetic characterization of glutamate transport into the Müller cells was performed as described in our previous study [15]. Primary Müller cells were cultured in 24-well plates and cells were treated with the relevant conditions for 24 hours. The cells were preincubated for 3 minutes at 37°C in HBSS (HEPES buffered saline solution; 142 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, and 10 mM HEPES) containing different concentration of L-glutamate (range 1–500 μM). Subsequently the Müller cells incubated for additionally 3 minutes in HBSS including trace amounts (1 : 200) of L-[3,4-3H]-glutamate (4 μCi/mL, Perkin-Elmer, Waltham, MA). The cellular content of radioactivity was determined in cells extracted in KOH and analysed by liquid scintillation counting in a Beckman LS6500 Liquid Scintillation Counter (Beckman Coulter, USA). Uptake rates were corrected for protein concentrations, which were measured in the cell extracts using BCA protein assay kit (Sigma-Aldrich). Unspecific uptake was determined by incubation at 0°C. Uptake kinetics was assumed to follow the normal Michaelis-Menten kinetics. The maximal uptake rate, , was determined using a nonlinear regression in GraphPad Prism 6 ().

2.9. Cocultures of RGCs and Müller Cells

To investigate the glia-neuron interactions, cocultures of RGCs and Müller cells were established. Primary Müller cells were precultured in Falcon 0.4 μm membrane inserts (Corning, USA) for 9 days in the DMEM used for normal cell culturing as described above. Likewise RGCs were cultured in coated 24-well plates for 5 days as detailed previously. When assembling the coculture, a complete medium change was performed for both RGCs and Müller cells with ND-growth medium. Subsequently, the inserts with Müller cells were placed into the wells containing RGCs, and the cocultures were maintained in a 37°C humidified atmosphere with 10% CO2 for 24 hours to examine cell viability following the conditions detailed above. To measure cell viability in cocultures media were collected for LDH analysis.

2.10. Statistical Analysis

All statistical analyses were performed in GraphPad Prism 6.0 software (GraphPad Software, USA) and values less than 0.05 were considered significant. The sample size of each experiment () has been determined from either a triplicate or more. All data are expressed as means ± SEM and differences between conditions were analysed using unpaired two-tailed tests when comparing two sets of data. If more groups of data were analysed, one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test was performed.

3. Results

3.1. Characterization of Primary Cell Cultures

To positively characterize the primary cell cultures as Müller cells and RGCs we performed immunocytochemical staining. During isolation of RGCs by the immunopanning technique we found some variability of the RGC homogeneity and to evaluate the purity of the isolation we performed immunocytochemical staining of RGCs. The staining confirmed the neuronal origin of the RGCs by demonstrating expression of GAP-43 (green, Figure 1) surrounding all nuclei stained with DAPI (blue, Figure 1). In contrast, the lack of GFAP staining in the cultures confirmed the absence of reactive macroglia. During some RGC preparations, we observed a degree of contamination by other cell types in the RGC cultures, probably from insufficient rinsing of the Thy-1 immunoplates. In such case, the prepared cells were discharged. The immunofluorescence labelling confirmed the expression of glutamine synthetase (GS) in the cytosol of the Müller cells (Figure 2(a)), which in the retina is selectively expressed in Müller cells [32]. The primary Müller cells also stained positive for the major glutamate transporter EAAT1 (Figure 2(b)).

3.2. Starvation and Simultaneous Mitochondrial Inhibition Decrease RGC and Müller Cell Survival

To evaluate the cytotoxic effects of starvation and mitochondrial inhibition by antimycin A on primary Müller cells and primary RGC cultures, we measured LHD levels. A significant decrease in RGC survival was found in response to 24 hours of starvation (Figure 3(a); 70% survival, ). Simultaneous starvation and exposure to antimycin A cause a more pronounced RGC death (Figure 3(a); 25% survival, ), whereas RGC survival was unaltered in cells solely exposed to antimycin A. A more significant and pronounced decrease of Müller cell viability was found due 24 hours of starvation (Figure 3(b); 42% survival, ). As with RGCs, Müller cell viability was further reduced during simultaneous starvation and treatment with antimycin A (Figure 3(b); 13% survival, ). Antimycin A exposure did not affect Müller cell viability in cells with sufficient energy supply.

3.3. Glutamate Increases Survival of Starved Müller Cells

A significant decrease in Müller cell viability due to starvation was confirmed using a MTT-based cell survival assay (Figure 4; 22%, ). By adding 1 mM glutamate the cytotoxic effect as a result of starvation was diminished (22% versus 39%; ), albeit it remained significantly reduced compared with the control (39%, ).

3.4. Starvation Increases Glutamate Uptake in Primary Müller Cells

To determine the influence of starvation on the glutamate uptake into primary Müller cells, glutamate uptake was analysed in response to 24 hours of starvation at 7 different extracellular concentrations of glutamate from 1 μM to 500 μM. Our study revealed a significantly increased and consistent uptake of glutamate throughout the experiment in particular at extracellular glutamate concentrations of 10, 25, and 100 μM glutamate (Figure 5(a); and ). Moreover, the relative was significantly increased upon starvation (, Figure 5(b)).

3.5. Cocultures to Study Glia-Neuron Interaction

RGCs were cultured in wells including an insert membrane containing primary Müller cells in close proximity, yet without anatomical contact. During this condition we found a significant impact on RGC survival in wells grown with Müller cells compared to RGCs cultured with an empty membrane insert (Figure 6(a); 1.3-fold, ). When prestarving the Müller cells for 24 hours, we demonstrated significant increase of RGC survival after coculturing for 24 hours (Figure 6(b); 1.4-fold, ). Moreover, we demonstrated a tendency towards an increased survival of RGCs in response to starvation (Figure 6(c); 1.2-fold, ). To evaluate the effect of Müller cells on RGC survival when mitochondrial functions were compromised, we cultured RGCs and Müller cells in presence of antimycin A. During compromised mitochondrial function, the Müller cells had significant impact on the RGC survival due to 24 hours of prestarvation (Figure 7(b); 1.4-fold, ). We found no protective effect of Müller cells on RGC survival in cells with sufficient energy availability after exposure to antimycin A. Similarly, no increased RGC survival was seen in starved cells exposed to antimycin A (Figures 7(a) and 7(c), resp.).

4. Discussion

RGC loss is a consequence of a variety of neurodegenerative diseases in the retina. Among the most common neurodegenerative retinal diseases are glaucoma and diabetic retinopathy [3335]. Glaucoma is the most common cause of irreversible blindness [36, 37]. It encompasses several conditions that all lead to progressive loss of RGCs and their axons [38]. Diabetic retinopathy is another blinding disease caused by damage and visual loss [35]. Most neurodegenerative retinal diseases are age-dependent and the burden is increasing due to an aging population [36, 37]. In this matter, neuroprotective strategies have been increasingly studied [37]. No current strategies have shown promise yet. Since RGCs remain unmyelinated and are protected only by the surrounding macroglial cells, it has been suggested that glia-neuron partnership is essential for RGC survival. However, only limited evidence exists on glia-neuron interactions in the retina. One of the first contemporary studies to present glia-neuron interplay was performed by Turner and Cepko [39]. The study proposed that Müller cells perform many of the metabolic, ionic, and extracellular buffering requirements of neurons [39]. In the following years, an interesting concept of cooperability between retinal neurons and Müller cells was proposed by Reichenbach et al. [40]. Additional studies reported important roles of Müller cells in transporting energy sources from the vessels to the neurons [41] as well as removing glutamate from the extracellular space by uptake carriers [42]. Another implication of the importance of glia-neuron interaction is the secretion of factors that favor neuronal survival by Müller cells [43].

In present study, we emphasize the importance of this cellular relationship by coculturing primary RGCs with primary Müller cells. Furthermore, we aimed to investigate the consequences of starvation and inhibition of mitochondrial function by antimycin A on these cocultures. It is well established that hypoglycemia may lead to retinal neuronal loss in vitro [1618]. The association between mitochondrial dysfunction and glaucoma has been reviewed [11, 44] and oxidative stress as a result of mitochondrial impairment has been connected to glaucomatous damage for several years [14]. We demonstrate that Müller cells increase RGC survival significantly during normal conditions and during starvation as well as prestarvation. Moreover, the presence of prestarved Müller cells promotes RGC survival during inhibited mitochondrial function. Since starvation causes decreased RGC and Müller cell survival the simultaneous increased ability of Müller cells to take up glutamate may indicate a protective mechanism that prevents glutamate-induced excitotoxicity. Altogether, our coculture model of primary RGCs and Müller cells confirms important roles of Müller cells in RGC survival. Previous studies have examined similar glia-neuron interactions. Furuya et al. demonstrated an increased survival rate in a coculture model of primary RGCs and Müller cells [27]. Moreover, Kawasaki et al. found a protective effect of primary Müller cells against glutamate excitotoxicity on primary RGCs [5]. A study by Matteucci et al. described Müller cell protection of RGCs against high-glucose conditions [28]. In fairness one study by Kashiwagi et al. showed opposite decreased RGC survival when cocultured with Müller cells [25]. All of the above-mentioned studies were performed with cell cultures originating from rats. To the best of our knowledge the present study is the first to describe the supporting role of Müller cells in RGC survival in primary cell cultures from mice as well as during prolonged starvation and mitochondrial inhibition, although the precise mechanism still needs elucidation. Previous studies examined the effect of various neurotrophic factors on RGC survival [30], including brain-derived neurotrophic factor (BDNF), which is produced by Müller cells in the retina [45]. BDNF is assumed to affect the survival of RGCs [46] and BDNF has been shown to upregulate GLAST and GS and furthermore to increase the glutamate uptake during hypoxia, of which the latter may accentuate the neuroprotective effects [47]. Pigment-epithelium-derived factor (PEDF) secreted by Müller cells is also contributing to the neuroprotective feature of Müller cells towards RGC survival [48]. An intravitreal PEDF transfection in a mouse model of glaucoma (DBA/2J mice) resulted in reduced loss of RGCs and the total nerve fiber layer, delayed vision loss, and reduced GFAP expression in the retina and optic nerve [49]. Ciliary neurotrophic factor (CNTF) has also been demonstrated to increase RGC survival after injury [46, 50]. Despite the fact that CNTF is not secreted by Müller cells, it has been suggested to modulate retinal glial cells into a more neuroprotective phenotype, which among others is characterized by a more efficient buffering of high concentrations of glutamate [51].

The glia-neuron partnership includes a range of decisive elements for the RGC homeostasis. Among these is the glutamate-glutamine cycle. In recent years, the focus on excitotoxicity [52, 53] has shifted from neuronal responses to glial regulations and responses to glutamate. Here, we demonstrate that Müller cells significantly increase their ability to take up glutamate during starvation. This finding extends our previous findings in the Müller cell line, MIO-M1, showing a similar increase in glutamate uptake during starvation [15]. However, we recently published a study demonstrating a diminished function of the glutamate uptake in Müller cells during simultaneous starvation and oxidative stress. These observations indicate a disturbed Müller cells homeostasis in presence of more than one environmental stressor [54]. Our coculture system provides a model to study glia-neuron interactions by permitting quantitative assessment of the effects of different stimuli on glial cells and neurons separately. Future implications of this system could allow manipulation of gene expression on only one cell type to enlighten the importance of specific proteins in the glia-neuron interplay.

The effects of 24 hours of starvation were evaluated by cell viability assays and surprisingly the experiments revealed greater vulnerability of Müller cells compared to RGCs. This observation indicates a greater robustness of RGCs to environmental stress such as starvation. This could be due to a more complex formulation of the ND-growth medium used for RGCs, whereas DMEM used for Müller cell cultures were not supplemented with various neurotrophic factors. Winkler et al. previously examined the viability of Müller cells upon 4 hours of starvation and the study showed a resistance of Müller cells to this relatively transient starvation [55]. A study by Wood et al. using a mixed retinal cell culture did indeed demonstrate that glial cells require a supply of glucose for survival in a culture upon 36 hours of starvation [56]. The sensibility of Müller cells upon starvation prompted us to analyse the Müller cell viability using another cell viability assay. Through MTT viability assays, the Müller cell viability was even further reduced due to 24 hours of starvation (Figure 4). Interestingly, the addition of glutamate to the starvation medium significantly increased the Müller cell survival indicating a capability of Müller cells to consume glutamate as an energy substrate. The oxidative metabolism of glutamate has been well described in brain astrocytes both in vitro and in vivo [5759]. On the contrary, the use of glutamate as an energy substrate is less described in Müller cells [41, 60]. Additionally, the vulnerability of Müller cells due to starvation potentially suggests a further increase of glutamate uptake into Müller cell than the uptake experiment might indicate (Figure 5(a)). The uptake experiment was corrected for mg protein and therefore the correction does not necessarily reflect viable cells with a functional glutamate uptake.

In conclusion we show that Müller cells promote RGC survival independently of anatomical interaction. Hence, secreted factors as well as increased removal of excess extracellular glutamate may be essential in RGC-Müller cell interactions. Overall, our study indicates essential roles of Müller cells in RGC-related neurodegenerative conditions. Strategies aiming at regulating the homeostasis of Müller cells might prove useful in preventing RGC loss. Current studies in our laboratory are addressing glucose and glutamate metabolism within Müller cells in greater details. Future studies are necessary to further assess the potential of Müller cells as pharmacological targets in treatment strategies of RGC-related inner retinal conditions.

Disclosure

The authors alone are responsible for the content and writing of the paper.

Competing Interests

The authors report no competing interests.

Authors’ Contributions

D. M. Skytt and A. K. Toft-Kehler have contributed equally to this paper.

Acknowledgments

The authors thank Laboratory Technician Hanne Panduro Olsen for skillful assistance to the study. Senior Consultant Jens Hannibal, Ph.D. DmSc, is cordially acknowledged for helping with the confocal microscopy images. The study was supported by the Velux Foundation, Denmark; Asta & Jul. P. Justesens Foundation, Denmark; Fight for Sight, Denmark; and the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

References

  1. E. Newman and A. Reichenbach, “The Müller cell: a functional element of the retina,” Trends in Neurosciences, vol. 19, no. 8, pp. 307–312, 1996. View at: Publisher Site | Google Scholar
  2. A. Bringmann and P. Wiedemann, “Müller glial cells in retinal disease,” Ophthalmologica, vol. 227, no. 1, pp. 1–19, 2011. View at: Publisher Site | Google Scholar
  3. E. Vecino, F. D. Rodriguez, N. Ruzafa, X. Pereiro, and S. C. Sharma, “Glia-neuron interactions in the mammalian retina,” Progress in Retinal and Eye Research, vol. 51, pp. 1–40, 2016. View at: Publisher Site | Google Scholar
  4. R. S. Chong and K. R. Martin, “Glial cell interactions and glaucoma,” Current Opinion in Ophthalmology, vol. 26, no. 2, pp. 73–77, 2015. View at: Publisher Site | Google Scholar
  5. A. Kawasaki, Y. Otori, and C. J. Barnstable, “Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity,” Investigative Ophthalmology and Visual Science, vol. 41, no. 11, pp. 3444–3450, 2000. View at: Google Scholar
  6. T. Harada, C. Harada, K. Nakamura et al., “The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma,” The Journal of Clinical Investigation, vol. 117, no. 7, pp. 1763–1770, 2007. View at: Publisher Site | Google Scholar
  7. K. R. G. Martin, H. Levkovitch-Verbin, D. Valenta, L. Baumrind, M. E. Pease, and H. A. Quigley, “Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2236–2243, 2002. View at: Google Scholar
  8. R. Naskar, C. K. Vorwerk, and E. B. Dreyer, “Concurrent downregulation of a glutamate transporter and receptor in glaucoma,” Investigative Ophthalmology and Visual Science, vol. 41, no. 7, pp. 1940–1944, 2000. View at: Google Scholar
  9. V. Chrysostomou, F. Rezania, I. A. Trounce, and J. G. Crowston, “Oxidative stress and mitochondrial dysfunction in glaucoma,” Current Opinion in Pharmacology, vol. 13, no. 1, pp. 12–15, 2013. View at: Publisher Site | Google Scholar
  10. N. N. Osborne and S. Del Olmo-Aguado, “Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma,” Current Opinion in Pharmacology, vol. 13, no. 1, pp. 16–22, 2013. View at: Publisher Site | Google Scholar
  11. S. Lee, N. J. Van Bergen, G. Y. Kong et al., “Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies,” Experimental Eye Research, vol. 93, no. 2, pp. 204–212, 2011. View at: Publisher Site | Google Scholar
  12. K. K. Abu-Amero and T. M. Bosley, “Mitochondrial abnormalities in patients with LHON-like optic neuropathies,” Investigative Ophthalmology and Visual Science, vol. 47, no. 10, pp. 4211–4220, 2006. View at: Publisher Site | Google Scholar
  13. A. Izzotti, A. Bagnis, and S. C. Saccà, “The role of oxidative stress in glaucoma,” Mutation Research—Reviews in Mutation Research, vol. 612, no. 2, pp. 105–114, 2006. View at: Publisher Site | Google Scholar
  14. G. Tezel, “Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences,” Progress in Retinal and Eye Research, vol. 25, no. 5, pp. 490–513, 2006. View at: Publisher Site | Google Scholar
  15. A. K. Toft-Kehler, D. M. Skytt, K. A. Poulsen et al., “Limited energy supply in Müller cells alters glutamate uptake,” Neurochemical Research, vol. 39, no. 5, pp. 941–949, 2014. View at: Publisher Site | Google Scholar
  16. X. Luo, G. N. Lambrou, J. A. Sahel, and D. Hicks, “Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro,” Investigative Ophthalmology and Visual Science, vol. 42, no. 11, pp. 2695–2705, 2001. View at: Google Scholar
  17. M. Emery, D. F. Schorderet, and R. Roduit, “Acute Hypoglycemia induces retinal cell death in mouse,” PLoS ONE, vol. 6, no. 6, article e21586, 2011. View at: Publisher Site | Google Scholar
  18. C. Romano, M. T. Price, T. Almli, and J. W. Olney, “Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina,” Investigative Ophthalmology and Visual Science, vol. 39, no. 2, pp. 416–423, 1998. View at: Google Scholar
  19. J. Flammer, S. Orgül, V. P. Costa et al., “The impact of ocular blood flow in glaucoma,” Progress in Retinal and Eye Research, vol. 21, no. 4, pp. 359–393, 2002. View at: Publisher Site | Google Scholar
  20. H. S. Chung, A. Harris, D. W. Evans, L. Kagemann, H. J. Garzozi, and B. Martin, “Vascular aspects in the pathophysiology of glaucomatous optic neuropathy,” Survey of Ophthalmology, vol. 43, supplement 1, pp. S43–S50, 1999. View at: Publisher Site | Google Scholar
  21. F. Fonnum, “Glutamate: a neurotransmitter in mammalian brain,” Journal of Neurochemistry, vol. 42, no. 1, pp. 1–11, 1984. View at: Publisher Site | Google Scholar
  22. T. Rauen, W. R. Taylor, K. Kuhlbrodt, and M. Wiessner, “High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance,” Cell and Tissue Research, vol. 291, no. 1, pp. 19–31, 1998. View at: Publisher Site | Google Scholar
  23. N. C. Danbolt, “Glutamate uptake,” Progress in Neurobiology, vol. 65, no. 1, pp. 1–105, 2001. View at: Publisher Site | Google Scholar
  24. G. A. Limb, T. E. Salt, P. M. G. Munro, S. E. Moss, and P. T. Khaw, “In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1),” Investigative Ophthalmology and Visual Science, vol. 43, no. 3, pp. 864–869, 2002. View at: Google Scholar
  25. K. Kashiwagi, Y. Iizuka, M. Araie, Y. Suzuki, and S. Tsukahara, “Effects of retinal glial cells on isolated rat retinal ganglion cells,” Investigative Ophthalmology and Visual Science, vol. 42, no. 11, pp. 2686–2694, 2001. View at: Google Scholar
  26. N. Ruzafa and E. Vecino, “Effect of Müller cells on the survival and neuritogenesis in retinal ganglion cells,” Archivos de la Sociedad Española de Oftalmología, vol. 90, no. 11, pp. 522–526, 2015. View at: Publisher Site | Google Scholar
  27. T. Furuya, Z. Pan, and K. Kashiwagi, “Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptor,” Current Eye Research, vol. 37, no. 3, pp. 170–178, 2012. View at: Publisher Site | Google Scholar
  28. A. Matteucci, L. Gaddini, M. Villa et al., “Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation,” Experimental Eye Research, vol. 125, pp. 20–29, 2014. View at: Publisher Site | Google Scholar
  29. T. A. Watkins, B. Emery, S. Mulinyawe, and B. A. Barres, “Distinct stages of myelination regulated by γ-secretase and astrocytes in a rapidly myelinating CNS coculture system,” Neuron, vol. 60, no. 4, pp. 555–569, 2008. View at: Publisher Site | Google Scholar
  30. A. Meyer-Franke, M. R. Kaplan, F. W. Pfieger, and B. A. Barres, “Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture,” Neuron, vol. 15, no. 4, pp. 805–819, 1995. View at: Publisher Site | Google Scholar
  31. D. Hicks and Y. Courtois, “The growth and behaviour of rat retinal Müller cells in vitro 1. An improved method for isolation and culture,” Experimental Eye Research, vol. 51, no. 2, pp. 119–129, 1990. View at: Publisher Site | Google Scholar
  32. R. E. Riepe and M. D. Norenburg, “Müller cell localisation of glutamine synthetase in rat retina,” Nature, vol. 268, no. 5621, pp. 654–655, 1977. View at: Publisher Site | Google Scholar
  33. H. V. Danesh-Meyer and L. A. Levin, “Glaucoma as a neurodegenerative disease,” Journal of Neuro-Ophthalmology, vol. 35, pp. S22–S28, 2015. View at: Publisher Site | Google Scholar
  34. M. Almasieh, A. M. Wilson, B. Morquette, J. L. Cueva Vargas, and A. Di Polo, “The molecular basis of retinal ganglion cell death in glaucoma,” Progress in Retinal and Eye Research, vol. 31, no. 2, pp. 152–181, 2012. View at: Publisher Site | Google Scholar
  35. J. G. Grigsby, S. M. Cardona, C. E. Pouw et al., “The role of microglia in diabetic retinopathy,” Journal of Ophthalmology, vol. 2014, no. 7, Article ID 705783, pp. 1–15, 2014. View at: Publisher Site | Google Scholar
  36. Y.-C. Tham, X. Li, T. Y. Wong, H. A. Quigley, T. Aung, and C.-Y. Cheng, “Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis,” Ophthalmology, vol. 121, no. 11, pp. 2081–2090, 2014. View at: Publisher Site | Google Scholar
  37. M. Kolko, “Present and new treatment strategies in the management of glaucoma,” The Open Ophthalmology Journal, vol. 9, no. 1, pp. 89–100, 2015. View at: Publisher Site | Google Scholar
  38. E. Garcia-Valenzuela, S. Shareef, J. Walsh, and S. C. Sharma, “Programmed cell death of retinal ganglion cells during experimental glaucoma,” Experimental Eye Research, vol. 61, no. 1, pp. 33–44, 1995. View at: Publisher Site | Google Scholar
  39. D. L. Turner and C. L. Cepko, “A common progenitor for neurons and glia persists in rat retina late in development,” Nature, vol. 328, no. 6126, pp. 131–136, 1987. View at: Google Scholar
  40. A. Reichenbach, A. Siegel, M. Rickmann, J. R. Wolff, D. Noone, and S. R. Robinson, “Distribution of bergmann glial somata and processes: implications for function,” Journal of Brain Research, vol. 36, no. 4, pp. 509–517, 1995. View at: Google Scholar
  41. A. Bringmann, T. Pannicke, B. Biedermann et al., “Role of retinal glial cells in neurotransmitter uptake and metabolism,” Neurochemistry International, vol. 54, no. 3-4, pp. 143–160, 2009. View at: Publisher Site | Google Scholar
  42. A. Derouiche and T. Rauen, “Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance,” Journal of Neuroscience Research, vol. 42, no. 1, pp. 131–143, 1995. View at: Publisher Site | Google Scholar
  43. A. Bringmann, I. Iandiev, T. Pannicke et al., “Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects,” Progress in Retinal and Eye Research, vol. 28, no. 6, pp. 423–451, 2009. View at: Publisher Site | Google Scholar
  44. G. Y. X. Kong, N. J. Van Bergen, I. A. Trounce, and J. G. Crowston, “Mitochondrial dysfunction and glaucoma,” Journal of Glaucoma, vol. 18, no. 2, pp. 93–100, 2009. View at: Publisher Site | Google Scholar
  45. M. Seki, T. Tanaka, Y. Sakai et al., “Müller cells as a source of brain-derived neurotrophic factor in the retina: noradrenaline upregulates brain-derived neurotrophic factor levels in cultured rat Müller cells,” Neurochemical Research, vol. 30, no. 9, pp. 1163–1170, 2005. View at: Publisher Site | Google Scholar
  46. C.-W. Zhang, Q. Lu, S.-W. You et al., “CNTF and BDNF have similar effects on retinal ganglion cell survival but differential effects on nitric oxide synthase expression soon after optic nerve injury,” Investigative Ophthalmology and Visual Science, vol. 46, no. 4, pp. 1497–1503, 2005. View at: Publisher Site | Google Scholar
  47. M. Dai, X.-B. Xia, and S.-Q. Xiong, “BDNF regulates GLAST and glutamine synthetase in mouse retinal Müller cells,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 596–603, 2012. View at: Publisher Site | Google Scholar
  48. J. D. Unterlauft, W. Eichler, K. Kuhne et al., “Pigment epithelium-derived factor released by mü ller glial cells exerts neuroprotective effects on retinal ganglion cells,” Neurochemical Research, vol. 37, no. 7, pp. 1524–1533, 2012. View at: Publisher Site | Google Scholar
  49. X. Zhou, F. Li, L. Kong, J. Chodosh, and W. Cao, “Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice,” Molecular Vision, vol. 15, pp. 438–450, 2009. View at: Google Scholar
  50. M. E. Pease, D. J. Zack, C. Berlinicke et al., “Effect of CNTF on retinal ganglion cell survival in experimental glaucoma,” Investigative Ophthalmology and Visual Science, vol. 50, no. 5, pp. 2194–2200, 2009. View at: Publisher Site | Google Scholar
  51. B. A. Van Adel, J. M. Arnold, J. Phipps, L. C. Doering, and A. K. Ball, “Ciliary neurotrophic factor protects retinal ganglion cells from axotomy-induced apoptosis via modulation of retinal glia in vivo,” Journal of Neurobiology, vol. 63, no. 3, pp. 215–234, 2005. View at: Publisher Site | Google Scholar
  52. R. J. Casson, “Possible role of excitotoxicity in the pathogenesis of glaucoma,” Clinical and Experimental Ophthalmology, vol. 34, no. 1, pp. 54–63, 2006. View at: Publisher Site | Google Scholar
  53. M. Seki and S. A. Lipton, “Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma,” Progress in Brain Research, vol. 173, pp. 495–510, 2008. View at: Publisher Site | Google Scholar
  54. A. K. Toft-Kehler, I. S. Gurubaran, C. Desler, L. J. Rasmussen, D. M. Skytt, and M. Kolko, “Oxidative stress-induced dysfunction of müller cells during starvation,” Investigative Opthalmology & Visual Science, vol. 57, no. 6, pp. 2721–2728, 2016. View at: Publisher Site | Google Scholar
  55. B. S. Winkler, M. J. Arnold, M. A. Brassell, and D. G. Puro, “Energy metabolism in human retinal Müller cells,” Investigative Ophthalmology & Visual Science, vol. 41, no. 10, pp. 3183–3190, 2000. View at: Google Scholar
  56. J. P. M. Wood, G. Chidlow, M. Graham, and N. N. Osborne, “Energy substrate requirements for survival of rat retinal cells in culture: the importance of glucose and monocarboxylates,” Journal of Neurochemistry, vol. 93, no. 3, pp. 686–697, 2005. View at: Publisher Site | Google Scholar
  57. H. R. Zielke, R. M. Collins Jr., P. J. Baab, Y. Huang, C. L. Zielke, and J. T. Tildon, “Compartmentation of [14C]glutamate and [14C]glutamine oxidative metabolism in the rat hippocampus as determined by microdialysis,” Journal of Neurochemistry, vol. 71, no. 3, pp. 1315–1320, 1998. View at: Google Scholar
  58. H. R. Zielke, C. L. Zielke, and P. J. Baab, “Oxidation of 14C-labeled compounds perfused by microdialysis in the brains of free-moving rats,” Journal of Neuroscience Research, vol. 85, no. 14, pp. 3145–3149, 2007. View at: Publisher Site | Google Scholar
  59. M. C. McKenna, “Glutamate pays its own way in astrocytes,” Frontiers in Endocrinology, vol. 4, article 191, 2013. View at: Publisher Site | Google Scholar
  60. S. Poitry, C. Poitry-Yamate, J. Ueberfeld, P. R. MacLeish, and M. Tsacopoulos, “Mechanisms of glutamate metabolic signaling in retinal glial (Müller) cells,” Journal of Neuroscience, vol. 20, no. 5, pp. 1809–1821, 2000. View at: Google Scholar

Copyright © 2016 D. M. Skytt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1557 Views | 517 Downloads | 16 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.